{
    "eid": "2-s2.0-85103394339",
    "title": "Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations",
    "cover-date": "2021-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Surgery",
            "@code": "2746",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Afatinib",
        "HER2 mutations",
        "Lung cancer",
        "Named patient use",
        "NSCLC",
        "Uncommon EGFR mutations"
    ],
    "authors": [
        "Gee Chen Chang",
        "David Chi Leung Lam",
        "Chun Ming Tsai",
        "Yuh Min Chen",
        "Jin Yuan Shih",
        "Shyam Aggarwal",
        "Shuhang Wang",
        "Sang We Kim",
        "Young Chul Kim",
        "Ibrahim Wahid",
        "Rubi Li",
        "Darren Wan Teck Lim",
        "Virote Sriuranpong",
        "Raymond Tsz Tong Chan",
        "Robert M. Lorence",
        "Philippe Carriere",
        "Christina Raabe",
        "Agnieszka Cseh",
        "Keunchil Park"
    ],
    "citedby-count": 2,
    "ref-count": 27,
    "ref-list": [
        "BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models",
        "Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker",
        "Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6",
        "Global named patient use program of afatinib in advanced non-small-cell lung carcinoma patients who progressed following prior therapies",
        "Afatinib in heavily pretreated advanced NSCLC patients who progressed following prior gefitinib or erlotinib: Compassionate use program in Korea",
        "Afatinib in non-small cell lung cancer harboring uncommon EGFR mutations pretreated with reversible EGFR inhibitors",
        "Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: The United Kingdom Named Patient Programme",
        "Experience with afatinib in patients with non-small cell lung cancer progressing after clinical benefit from gefitinib and erlotinib",
        "Activity of afatinib in heavily pretreated patients with ERBB2 mutation-positive advanced NSCLC: Findings from a global named patient use program",
        "Worldwide frequency of commonly detected EGFR mutations",
        "Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): A phase 2b/3 randomised trial",
        "Afatinib named patient use program in advanced NSCLC with progression on prior therapy: Experience from Asian centers. IASLC Asia Conference on Lung Cancer. Guangzhou, China",
        "Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutations",
        "Effectiveness of tyrosine kinase inhibitors on \u201cuncommon\u201d epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer",
        "Response heterogeneity of EGFR and HER2 Exon 20 insertions to covalent EGFR and HER2 inhibitors",
        "Natural history and molecular characteristics of lung cancers harboring EGFR exon 20 insertions",
        "Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib",
        "Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer",
        "Epidermal growth factor receptor tyrosine kinase inhibitor-sensitive exon 19 insertion and exon 20 insertion in patients with advanced non-small-cell lung cancer",
        "Afatinib for an EGFR exon 20 insertion mutation: A case report of progressive stage IV metastatic lung adenocarcinoma with 54 months\u2019 survival",
        "Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients",
        "Somatic mutations of the HER2 kinase domain in lung adenocarcinomas",
        "Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas",
        "Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: Mutations are mainly present in adenocarcinomas with bronchioloalveolar features",
        "Lung cancer: Intragenic ERBB2 kinase mutations in tumours",
        "Osimertinib in pretreated T790M-positive advanced non-small-cell lung cancer: AURA study phase II extension component",
        "An open-label, multicenter, phase II single arm trial of osimertinib in non-small cell lung cancer patients with uncommon EGFR mutation (KCSG-LU15-09)"
    ],
    "affiliation": [
        {
            "affiliation-city": "Taipei",
            "@id": "60013314",
            "affilname": "Veterans General Hospital-Taipei",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013314",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Ridgefield",
            "@id": "60105084",
            "affilname": "Boehringer Ingelheim Pharmaceuticals, Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60105084",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Taichung",
            "@id": "60073390",
            "affilname": "Chung Shan Medical University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073390",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Taipei",
            "@id": "60073385",
            "affilname": "National Taiwan University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60073385",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60031809",
            "affilname": "National Cancer Centre, Singapore",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031809",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Vienna",
            "@id": "60031368",
            "affilname": "Boehringer Ingelheim GmbH Austria",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031368",
            "affiliation-country": "Austria"
        },
        {
            "affiliation-city": "Taichung",
            "@id": "60027767",
            "affilname": "Chung Shan Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027767",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "New Delhi",
            "@id": "60024218",
            "affilname": "Sir Ganga Ram Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024218",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Suwon",
            "@id": "60016329",
            "affilname": "SKKU School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016329",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Ingelheim am Rhein",
            "@id": "60011807",
            "affilname": "Boehringer Ingelheim Pharma GmbH &amp; Co. KG",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011807",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60008510",
            "affilname": "Beijing Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008510",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Gwangju",
            "@id": "60007215",
            "affilname": "Chonnam National University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007215",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60006541",
            "affilname": "The University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006541",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60006240",
            "affilname": "University of Ulsan College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Taichung",
            "@id": "60006121",
            "affilname": "Veterans General Hospital-Taichung Taiwan",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006121",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Petaling Jaya",
            "@id": "113699696",
            "affilname": "Beacon International Specialist Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113699696",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Quezon City",
            "@id": "112643991",
            "affilname": "St. Luke\u2019s Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112643991",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "101944279",
            "affilname": "Hong Kong Integrated Oncology Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101944279",
            "affiliation-country": "Hong Kong"
        }
    ],
    "funding": [
        "Boehringer Ingelheim Inc."
    ]
}